Aveo Pharmaceuticals, INC.
SEC CIK 1325879 · AVEO · last insider filing 2023-01-19
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Bate Kenneth | Director | filed 2010 - 2023 |
| Evnin Anthony B | Director | filed 2010 - 2023 |
| Bailey Michael P | Director · President & CEO | filed 2010 - 2023 |
| Mayes, Gregory T. | Director | filed 2019 - 2023 |
| Spring Scarlett | Director | filed 2019 - 2023 |
| Epperly Corinne | Director | filed 2021 - 2023 |
| Cullen Kevin Joseph | Director | filed 2021 - 2023 |
| Young Robert C | Director · President & CEO | filed 2010 - 2020 |
| Johnson John H | Director | filed 2018 - 2018 |
| Termeer Henri A | Director | filed 2011 - 2016 |
| Kucherlapati Raju S | Director | filed 2010 - 2015 |
| HA Ngoc Tuan | Director · President & CEO | filed 2010 - 2015 |
| WEG Kenneth E | Director | filed 2010 - 2013 |
| Epstein Robert S | Director | filed 2012 - 2012 |
| Depinho Ronald A | Director | filed 2010 - 2012 |
| Galakatos Nicholas | Director | filed 2010 - 2011 |
| Cole Douglas G. | Director | filed 2010 - 2011 |
| Hirsch Russell C | Director | filed 2010 - 2010 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lucera Erick | Chief Financial Officer | filed 2020 - 2023 |
| Ferraresso Michael | Chief Commercial Officer | filed 2021 - 2023 |
| Ledell Jebediah | Chief Operating Officer | filed 2021 - 2023 |
| Needle Michael N | Chief Medical Officer | filed 2015 - 2021 |
| Rubin Karuna | Senior VP and General Counsel | filed 2018 - 2020 |
| Dallas Matthew D | VP, Finance | filed 2014 - 2019 |
| Mehta Nikhil | See Remarks | filed 2017 - 2019 |
| Ehrlich Keith S | Chief Financial Officer | filed 2015 - 2017 |
| Gyuris Jeno | SVP, Head of Research | filed 2010 - 2015 |
| Vittiglio Joseph | VP, Chief Corporate Counsel | filed 2012 - 2015 |
| Slichenmyer William | Chief Medical Officer | filed 2010 - 2014 |
| Johnston David Brannon | Chief Financial Officer | filed 2010 - 2013 |
| Jones Mary Ellen | SVP, Human Resources | filed 2012 - 2013 |
| Ezickson Elan | Chief Operating Officer | filed 2010 - 2013 |
| Robinson Murray O. | SVP, Translational Medicine | filed 2012 - 2012 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.